Lymphatic Complications Following Sentinel Node Biopsy or Pelvic Lymphadenectomy for Endometrial Cancer.

endometrial cancer lower-extremity lymphedema sentinel lymph node

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
07 Jul 2023
Historique:
received: 18 05 2023
revised: 29 06 2023
accepted: 30 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Sentinel node biopsy (SNB) is performed worldwide in patients with endometrial cancer (EC). The aim of this study was to evaluate and compare the occurrence rate of lymphatic complications between SNB and pelvic lymphadenectomy (LND) for EC. The medical records of women who underwent SNB or pelvic LND for EC between September 2012 and April 2022 were assessed. A total of 388 patients were enrolled in the current study. Among them, 201 patients underwent SNB and 187 patients underwent pelvic LND. The occurrence rates of lower-extremity lymphedema (LEL) and pelvic lymphocele (PL) were compared between the patients who underwent SNB and those who underwent pelvic LND. The SNB group had a significantly lower occurrence rate of lower-extremity LEL than the pelvic LND group (2.0% vs. 21.3%,

Identifiants

pubmed: 37445574
pii: jcm12134540
doi: 10.3390/jcm12134540
pmc: PMC10342261
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lymphology. 2016 Dec;49(4):170-84
pubmed: 29908550
Pathol Oncol Res. 2020 Oct;26(4):2273-2279
pubmed: 32458294
Gynecol Oncol. 1995 Jan;56(1):29-33
pubmed: 7821843
J Clin Med. 2022 Oct 31;11(21):
pubmed: 36362690
Int J Clin Oncol. 2018 Apr;23(2):305-313
pubmed: 29098518
Gynecol Oncol. 2021 Jan;160(1):244-251
pubmed: 33109392
Cancer Res Treat. 2004 Dec;36(6):377-83
pubmed: 20368832
Am J Obstet Gynecol. 2019 Mar;220(3):263.e1-263.e8
pubmed: 30521798
Gynecol Oncol. 2018 Mar;148(3):491-498
pubmed: 29273307
Gynecol Oncol. 2023 Mar;170:273-281
pubmed: 36738486
Lancet. 2009 Jan 10;373(9658):125-36
pubmed: 19070889
Minerva Ginecol. 2018 Apr;70(2):194-214
pubmed: 29185673
Transl Cancer Res. 2019 Oct;8(6):2218-2219
pubmed: 35116973
Surg Endosc. 2022 Oct;36(10):7114-7125
pubmed: 35467142
Arch Gynecol Obstet. 2019 Sep;300(3):683-691
pubmed: 31256231
Am J Obstet Gynecol. 2021 Oct;225(4):367.e1-367.e39
pubmed: 34058168
Int J Gynecol Cancer. 2021 Jan;31(1):85-91
pubmed: 33243776
Eur J Surg Oncol. 2021 Aug;47(8):2142-2149
pubmed: 33820674
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):255-61
pubmed: 17624991
Obstet Gynecol Sci. 2017 Sep;60(5):440-448
pubmed: 28989920
Gynecol Oncol. 2020 Jan;156(1):147-153
pubmed: 31780238
Cancer. 2006 Oct 15;107(8):1823-30
pubmed: 16977653
J Clin Med. 2020 Oct 02;9(10):
pubmed: 33023211
J Minim Invasive Gynecol. 2020 May - Jun;27(4):938-945.e2
pubmed: 31421249
Medicine (Baltimore). 2018 Sep;97(38):e12522
pubmed: 30235772
Gynecol Oncol. 2020 Feb;156(2):467-474
pubmed: 31837831
Gynecol Oncol. 2015 May;137(2):291-8
pubmed: 25720294
Int J Gynecol Cancer. 2015 May;25(4):751-7
pubmed: 25723779
Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:112-121
pubmed: 28242470
Healthcare (Basel). 2019 Aug 27;7(3):
pubmed: 31461980
Gynecol Oncol. 2020 Aug;158(2):375-381
pubmed: 32499070
Int J Clin Oncol. 2020 Nov;25(11):1985-1994
pubmed: 32648131
Gynecol Oncol. 1991 Jan;40(1):55-65
pubmed: 1989916
Gynecol Oncol. 2016 Jun;141(3):440-446
pubmed: 27020700
Exp Ther Med. 2020 Dec;20(6):181
pubmed: 33101471
Gynecol Oncol. 2020 Oct;159(1):201-208
pubmed: 32763108
Int J Gynecol Cancer. 2020 Feb;30(2):252-260
pubmed: 31915136
J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16
pubmed: 19033573
Br J Cancer. 2007 Sep 3;97(5):605-11
pubmed: 17667929
Lancet Oncol. 2017 Mar;18(3):384-392
pubmed: 28159465
Gynecol Oncol. 2019 Dec;155(3):452-460
pubmed: 31679787
Gynecol Oncol. 1998 Dec;71(3):340-3
pubmed: 9887227
Int J Gynecol Cancer. 2020 Jan;30(1):41-47
pubmed: 31780567
Eur J Gynaecol Oncol. 2003;24(3-4):327-9
pubmed: 12807250
Gynecol Oncol. 2009 May;113(2):163-9
pubmed: 19232699
Gynecol Oncol. 2016 Dec;143(3):479-483
pubmed: 27776838
Cochrane Database Syst Rev. 2017 Oct 02;10:CD007585
pubmed: 28968482
Gynecol Oncol. 2016 May;141(2):206-210
pubmed: 26905211

Auteurs

Shinichi Terada (S)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Tomohito Tanaka (T)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.
Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Hikaru Murakami (H)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Hiromitsu Tsuchihashi (H)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Akihiko Toji (A)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Atsushi Daimon (A)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Shunsuke Miyamoto (S)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.
Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Ruri Nishie (R)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Shoko Ueda (S)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Sousuke Hashida (S)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Natsuko Morita (N)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Hiroshi Maruoka (H)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Hiromi Konishi (H)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Yuhei Kogata (Y)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Kohei Taniguchi (K)

Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Kazumasa Komura (K)

Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Masahide Ohmichi (M)

Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka 569-0801, Japan.

Classifications MeSH